• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: UNITED THERAPEUTICS TYVASO INHALATION SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

UNITED THERAPEUTICS TYVASO INHALATION SYSTEM Back to Search Results
Model Number TD-100/A
Device Problem Device Operates Differently Than Expected (2913)
Patient Problems Dizziness (2194); No Code Available (3191)
Event Type  Injury  
Event Description
Pump bubbles all the time with pause when you breathe [device - malfunction].Bitter taste in mouth [taste bitter].Dizziness [cough].Case description: this case is a spontaneous report from the united states regarding a report received from a consumer via a specialty pharmacy.Add'l info was received from the pt on (b)(6) 2014.Add'l info was received on (b)(6) 2014.The pt was a (b)(6) female of unk height and race who first received tyvaso (treprostinil) on (b)(6) 2013 for primary pulmonary hypertension.Inhaled (ih) treprostinil dose was 18-54 micrograms (3-9 breaths), four times daily (qid) at the time of the event.The pt reported that one pump did not work (td100 or td100 a with serial numbers (b)(4) or (b)(4) respectively) and it bubbled all the time, without a pause when she took a breath.The pt also noted that she felt dizzy after 4-5 puffs, like she got too much medication.She switched to other pump, which functioned as expected, and noted no dizziness.She tried the first pump again, and the pump issues reoccurred with quick dizziness and increased cough.The pt also had a bitter taste in mouth after each time this happened.The td100 device was replaced.The outcomes of the events of bitter taste in mouth, dizziness, cough and pump bubbles all the time with pause when you breathe unk.Diagnosis for use: primary pulmonary hypertension (pulmonary arterial hypertension).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
TYVASO INHALATION SYSTEM
Type of Device
TYVASO INHALATION SYSTEM
Manufacturer (Section D)
UNITED THERAPEUTICS
MDR Report Key4443261
MDR Text Key5379818
Report NumberMW5040330
Device Sequence Number1
Product Code CAF
Number of Events Reported1
Summary Report (Y/N)N
Report Source Voluntary
Type of Report Initial
Report Date 08/07/2014
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Model NumberTD-100/A
Initial Date Manufacturer Received Not provided
Initial Date FDA Received09/30/2014
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
18-54 MICROGRAMS, QID, INHALATION:; LOT #2100387, EXP: 07/31/2015; 0.6MG/ML; TRACLEER/01587724 (BOSENTAN); TYVASO (TREPROSTINIL SODIUM) INHALATION GAS,
Patient Age68 YR
Patient Weight80
-
-